派博傳思國(guó)際中心

標(biāo)題: Titlebook: Global Perspectives on Precision Medicine; Ethical, Social and Evangel Sarwar Book 2023 The Editor(s) (if applicable) and The Author(s), u [打印本頁(yè)]

作者: Concave    時(shí)間: 2025-3-21 18:44
書目名稱Global Perspectives on Precision Medicine影響因子(影響力)




書目名稱Global Perspectives on Precision Medicine影響因子(影響力)學(xué)科排名




書目名稱Global Perspectives on Precision Medicine網(wǎng)絡(luò)公開度




書目名稱Global Perspectives on Precision Medicine網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Global Perspectives on Precision Medicine被引頻次




書目名稱Global Perspectives on Precision Medicine被引頻次學(xué)科排名




書目名稱Global Perspectives on Precision Medicine年度引用




書目名稱Global Perspectives on Precision Medicine年度引用學(xué)科排名




書目名稱Global Perspectives on Precision Medicine讀者反饋




書目名稱Global Perspectives on Precision Medicine讀者反饋學(xué)科排名





作者: Rankle    時(shí)間: 2025-3-21 23:40

作者: 入伍儀式    時(shí)間: 2025-3-22 04:25

作者: Jubilation    時(shí)間: 2025-3-22 08:16

作者: sperse    時(shí)間: 2025-3-22 10:10

作者: 建筑師    時(shí)間: 2025-3-22 13:29

作者: 建筑師    時(shí)間: 2025-3-22 17:28
Book 2023nticipated ethical and social implications. It is the first book that critically analyzes?.the potential and the dilemmas.?relevant to genomics and precision medicine from healthcare, public health and global perspectives. The nine chapters presented in this book elaborate on pharmacogenomics‘ cruci
作者: 確保    時(shí)間: 2025-3-22 22:29
2212-652X rom a clinical healthcare, public health and global perspect.This book presents the promises of Precision Medicine (PM) and the challenges of its implementation in daily clinical routine, while addressing the anticipated ethical and social implications. It is the first book that critically analyzes?
作者: CHOKE    時(shí)間: 2025-3-23 03:00

作者: phase-2-enzyme    時(shí)間: 2025-3-23 09:07
,Clinical Significance of Precision Medicine – Genomics and Pharmacogenomics (PGx),munities leading to inequities in access to much needed targeted therapies for communicable and noncommunicable diseases pertaining to the needs of developing and resource-poor countries, thereby increasing health disparities. This chapter looks at clinical significance of PGx for both developed and
作者: AV-node    時(shí)間: 2025-3-23 10:42
Relevance of PM in Infectious and Non-communicable Chronic Diseases and Pandemics, of people each year globally. Despite all these advantages, it will be difficult to navigate through the challenges and the ethical and social issues that are anticipated to arise for the clinical practice, public health, and policy making in the era of PM. This chapter looks at the importance of P
作者: 天空    時(shí)間: 2025-3-23 15:15

作者: Interlocking    時(shí)間: 2025-3-23 18:48

作者: FLIRT    時(shí)間: 2025-3-23 23:50

作者: bibliophile    時(shí)間: 2025-3-24 04:42
Education and Competency Rich in Genomics and Ethics Is a Necessity for Healthcare Professionals ines, it has been identified that there is a need for health provider education and competency rich in genomics and ethics. Lack of PCP’s knowledge in ordering genomic tests has been an indicator in lack of PCP’s confidence in ordering genomic tests for patients. The purpose of this chapter is to look
作者: Ledger    時(shí)間: 2025-3-24 08:22
Concluding Thoughts,Christensen (2016) point out, PM would be ideal for diseases such as cancer since some of the best-in-class drugs are reported to be ineffective in 20–30% of all cases, and a five-year survival rate for most metastasized cases are less than 10% – therefore, cancer could significantly benefit from th
作者: 擦掉    時(shí)間: 2025-3-24 14:45
Meeting Children Where They ArePM initiative. Although, PM is held at a high esteem as the innovative technology in healthcare, it has been argued that implementing PM into routine clinical setting will need to address considerable challenges that include addressing ethical issues and making sure PM research and technology is equ
作者: 決定性    時(shí)間: 2025-3-24 17:21
Michael McCahill MA,Clive Norrismunities leading to inequities in access to much needed targeted therapies for communicable and noncommunicable diseases pertaining to the needs of developing and resource-poor countries, thereby increasing health disparities. This chapter looks at clinical significance of PGx for both developed and
作者: 克制    時(shí)間: 2025-3-24 21:19
The Missing Mass Mystery Unfolds, of people each year globally. Despite all these advantages, it will be difficult to navigate through the challenges and the ethical and social issues that are anticipated to arise for the clinical practice, public health, and policy making in the era of PM. This chapter looks at the importance of P
作者: wangle    時(shí)間: 2025-3-25 01:32
Invisible Work, Invisible Workersocial concerns, such as the fear of raising the 10/90 gap between developed and developing countries due to PM. With the goal of looking at PM in public health and global health genomics, this chapter will focus on the relevance of PM in the developed and developing countries, while discussing the a
作者: 催眠藥    時(shí)間: 2025-3-25 03:33

作者: 不能逃避    時(shí)間: 2025-3-25 08:54
https://doi.org/10.1007/978-3-642-65012-3ings by administering treatments only to those most likely to benefit, but a clear roadmap is needed to advance PM by understanding and overcoming the challenges by healthcare organizations (HCOs) such as costs, and ethical obligations of HCOs. This chapter focuses on the healthcare organizational e
作者: 遺留之物    時(shí)間: 2025-3-25 13:06

作者: insecticide    時(shí)間: 2025-3-25 16:35
https://doi.org/10.1007/978-3-658-14489-0Christensen (2016) point out, PM would be ideal for diseases such as cancer since some of the best-in-class drugs are reported to be ineffective in 20–30% of all cases, and a five-year survival rate for most metastasized cases are less than 10% – therefore, cancer could significantly benefit from th
作者: 詞匯    時(shí)間: 2025-3-25 20:13

作者: 種族被根除    時(shí)間: 2025-3-26 03:44
2212-652X identifies and addresses the lack of competency in the healthcare workforce in the era of PM and discusses the path to laying the ethical foundation for the implementation of PM in healthcare organizations..978-3-031-28595-0978-3-031-28593-6Series ISSN 2212-652X Series E-ISSN 2212-6538
作者: 小步舞    時(shí)間: 2025-3-26 05:47
Analysis of Barriers to Invisible Trade,pros and cons of this technology. President Obama’s launch of the Precision Medicine Initiative (PMI) in 2015 has helped PM to get the momentum it needs to be implemented in clinical settings. Champions of PM have made many promises of benefits – which will have global impact. However, the interpret
作者: 虛度    時(shí)間: 2025-3-26 12:01
Meeting Children Where They Areng a “deep understanding” of patients’ genetic and genomic information, thereby moving away from the current “one-size-fits-all” treatment. Since the launch of the Precision Medicine Initiative in 2015 by the Obama administration, the United States, along with countries including Canada, the United
作者: Digest    時(shí)間: 2025-3-26 16:18
Michael McCahill MA,Clive Norrisugs and dosages, and will be one of the first clinical applications of the PM. It has been expected that the reduction in trial and error as a result of PGx would lead to efficacious drugs, thereby preventing avoidable deaths, costly hospitalizations and wastage resulting from adverse reactions (ADR
作者: 蕁麻    時(shí)間: 2025-3-26 20:42
The Missing Mass Mystery Unfolds, patient’s genetic profile, by analyzing the coding and structural variants in a patient’s genome to provide information about the causes of existing conditions, future risks for disease, and responsiveness to drugs. PM’s major future goals include preventing premature deaths, reduction of healthcar
作者: Blazon    時(shí)間: 2025-3-26 23:14

作者: infringe    時(shí)間: 2025-3-27 01:33
Ultraheavy Cosmic Rays — HEAO-3 Resultstion with Family History and other environmental factors. As such, implementation of PM requires diverse genomic data, to develop optimal methods for information delivery for all, not just for people from European ancestry as observed today. However, in order to increase public participation, there
作者: 橫條    時(shí)間: 2025-3-27 07:44

作者: Hallmark    時(shí)間: 2025-3-27 10:19

作者: 我就不公正    時(shí)間: 2025-3-27 15:43

作者: Genteel    時(shí)間: 2025-3-27 21:09

作者: Panther    時(shí)間: 2025-3-27 22:58

作者: 不適    時(shí)間: 2025-3-28 02:06

作者: ADJ    時(shí)間: 2025-3-28 07:53

作者: Protein    時(shí)間: 2025-3-28 12:27

作者: 儀式    時(shí)間: 2025-3-28 16:05
Social and Ethical Implications of Integrating Precision Medicine into Healthcare,tion with Family History and other environmental factors. As such, implementation of PM requires diverse genomic data, to develop optimal methods for information delivery for all, not just for people from European ancestry as observed today. However, in order to increase public participation, there
作者: giggle    時(shí)間: 2025-3-28 22:07
Laying an Ethical Foundation in Healthcare in the Era of PM,ears to come. With better targeted treatment and diagnosis, PM is anticipated to produce increased high-quality and low-cost healthcare to all. Despite the many benefits of PM, researchers anticipate many broader issues associated with the genomic information/knowledge such as privacy, discriminatio




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
平凉市| 莱西市| 双城市| 林西县| 和林格尔县| 商洛市| 盘锦市| 泊头市| 安丘市| 湛江市| 永修县| 伊吾县| 丹阳市| 丹江口市| 百色市| 临海市| 安溪县| 太谷县| 河西区| 四川省| 巴彦县| 习水县| 洛阳市| 满城县| 桑植县| 绥芬河市| 丹棱县| 灯塔市| 修水县| 东兰县| 新竹县| 天长市| 榕江县| 岐山县| 盘锦市| 肥乡县| 丰镇市| 瓦房店市| 喀喇沁旗| 建湖县| 杭州市|